BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37517767)

  • 1. Amide proton transfer weighted MRI in differential diagnosis of ovarian masses with cystic components: A preliminary study.
    Yu Y; Song X; Zeng Z; Wang L; Zhang L; Zhao H; Zheng Z
    Magn Reson Imaging; 2023 Nov; 103():216-223. PubMed ID: 37517767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
    Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
    Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging.
    Xu Y; Wan Q; Ren X; Jiang Y; Wang F; Yao J; Wu P; Shen A; Wang P
    Magn Reson Imaging; 2024 Feb; 106():104-109. PubMed ID: 38135260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ovarian endometriotic cysts in cystic lesions of the ovary by amide proton transfer-weighted imaging and R2∗ mapping.
    Li Y; Lu X; Chen L; Zhang Q; Wang N; Wang J; Lin L; Hu G; Zhang Y; Liu A
    Clin Radiol; 2023 Feb; 78(2):e106-e112. PubMed ID: 36334944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive Differentiation of Endometrial Adenocarcinoma from Benign Lesions in the Uterus by Utilization of Amide Proton Transfer-Weighted MRI.
    Li Y; Lin CY; Qi YF; Wang XQ; Chen B; Zhou HL; Ren J; Yang JJ; Xiang Y; He YL; Xue HD; Jin ZY
    Mol Imaging Biol; 2021 Jun; 23(3):446-455. PubMed ID: 33185840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of fibroadenomas versus malignant breast tumors utilizing three-dimensional amide proton transfer weighted magnetic resonance imaging.
    Zhang N; Kang J; Wang H; Liu A; Miao Y; Ma X; Song Q; Zhang L; Wang J; Shen Z; Xu X
    Clin Imaging; 2022 Jan; 81():15-23. PubMed ID: 34597999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional turbo-spin-echo amide proton transfer-weighted mri for cervical cancer: A preliminary study.
    He YL; Li Y; Lin CY; Qi YF; Wang X; Zhou HL; Yang JJ; Xiang Y; Xue HD; Jin ZY
    J Magn Reson Imaging; 2019 Oct; 50(4):1318-1325. PubMed ID: 30859696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-tumor amide proton transfer-weighted imaging histogram analysis to predict pathological extramural venous invasion in rectal adenocarcinoma: a preliminary study.
    Chen W; Liu G; Chen J; Wei Q; Ye Y; Du X; Feng J; Yan Z; Deng K; Liu X
    Eur Radiol; 2023 Jul; 33(7):5159-5171. PubMed ID: 36700956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional turbo-spin-echo amide proton transfer-weighted and intravoxel incoherent motion MR imaging for type I endometrial carcinoma: Correlation with Ki-67 proliferation status.
    Li Y; Lin CY; Qi YF; Wang X; Chen B; Zhou HL; Ren J; Yang JJ; Xiang Y; He YL; Xue HD; Jin ZY
    Magn Reson Imaging; 2021 May; 78():18-24. PubMed ID: 33556484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T.
    Friismose AI; Markovic L; Nguyen N; Gerke O; Schulz MK; Mussmann BR
    Radiography (Lond); 2022 Feb; 28(1):95-101. PubMed ID: 34509365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimension amide proton transfer MRI of rectal adenocarcinoma: correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging.
    Chen W; Li L; Yan Z; Hu S; Feng J; Liu G; Liu B; Liu X
    Eur Radiol; 2021 May; 31(5):3286-3296. PubMed ID: 33125558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
    Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.
    Xiang Y; Zhang Q; Chen X; Sun H; Li X; Wei X; Zhong J; Gao B; Huang W; Liang W; Sun H; Yang Q; Ren X
    Eur Radiol; 2024 Mar; ():. PubMed ID: 38491129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional amide proton transfer-weighted and intravoxel incoherent motion imaging for predicting bone metastasis in patients with prostate cancer: A pilot study.
    Hu W; Chen L; Lin L; Wang J; Wang N; Liu A
    Magn Reson Imaging; 2023 Feb; 96():8-16. PubMed ID: 36375760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.
    Jiang S; Rui Q; Wang Y; Heo HY; Zou T; Yu H; Zhang Y; Wang X; Du Y; Wen X; Chen F; Wang J; Eberhart CG; Zhou J; Wen Z
    Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
    Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
    Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining amide proton transfer-weighted and arterial spin labeling imaging to differentiate solitary brain metastases from glioblastomas.
    Chen L; Li T; Li Y; Zhang J; Li S; Zhu L; Qin J; Tang L; Zeng Z
    Magn Reson Imaging; 2023 Oct; 102():96-102. PubMed ID: 37172748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amide Proton Transfer-weighted MRI in Predicting Histologic Grade of Bladder Cancer.
    Wang HJ; Cai Q; Huang YP; Li MQ; Wen ZH; Lin YY; Ouyang LY; Qian L; Guo Y
    Radiology; 2022 Oct; 305(1):127-134. PubMed ID: 35762886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
    Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
    Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.